Showing results (591-600 of 607) with videos related to
Sort By:
Pageof 61
Nature Communications|September 24, 2015
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in miceRebecca Deprez-Poulain, Nathalie Hennuyer, Damien Bosc, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 2024
Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohortDavid Tougeron, Frederic Bibeau, Benoist Chibaudel, et al.Cancer Research|June 16, 2023
CD36 Drives Metastasis and Relapse in Acute Myeloid LeukemiaThomas Farge, Jean Nakhle, Damien Lagarde, et al.British Journal of Pharmacology|March 19, 2026
Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin-degrading enzyme, a new molecular vulnerability in multiple myelomaLaetitia Lesire, Rebecca Deprez-Poulain, Damien Bosc, et al.Cancer Discovery|July 10, 2020
Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid LeukemiaNesrine Aroua, Emeline Boet, Margherita Ghisi, et al.Journal of Viral Hepatitis|May 20, 2003
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled studyI Portal, M Bourlière, P Halfon, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 4, 2023
International consensus recommendations on face transplantation: A 2-step Delphi studyBenedetto Longo, Fay Bound Alberti, Bohdan Pomahac, et al.Leukemia|March 31, 2022
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemiaJustine Decroocq, Rudy Birsen, Camille Montersino, et al.Communications Biology|October 16, 2020
Network integration and modelling of dynamic drug responses at multi-omics levelsNathalie Selevsek, Florian Caiment, Ramona Nudischer, et al.Nature Cancer|February 5, 2022
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemiaClaudie Bosc, Estelle Saland, Aurélie Bousard, et al.Pageof 61